The STREAM2 trial: How should we treat multi-drug resistant tuberculosis?

For World TB Day, this episode explores the global burden of tuberculosis (TB) and how growing antibiotic resistance can complicate treatment options. Andrew Nunn, a Professor of Epidemiology, discusses his work on the STREAM2 trial, which investigated how treatment for multi-drug resistant TB could be shortened and made more acceptable for patients.

Further information is available on the STREAM Stage 2 study page at www.mrcctu.ac.uk and results from STREAM2 are published open access in The Lancet.

For questions or feedback on the series, message us at [email protected]

For more information and to access the transcript: http://bit.ly/3TDnz24

As a listener, your opinion is very valuable to us. Please help us to improve the podcast in future by filling in this short survey: https://forms.office.com/e/PjfjQ5Mn6g